Tasly Pharmaceutical (600535.SH) subsidiary receives drug registration certificate for indocyanine green for injection

Zhitong Finance APP News, Tianshili (600535.SH) announced that recently, its wholly-owned subsidiary Tianjin Tianshili Zhijiao Pharmaceutical Co., Ltd. received the "Drug Registration Certificate" for Indocyanine Green for Injection approved and issued by the National Medical Products Administration. Indocyanine Green for Injection is clinically used for diagnosing various liver diseases such as cirrhosis, liver fibrosis, persistent hepatitis, and occupational and drug-induced toxic liver disease, to understand the degree of liver damage and its reserve function; it can also be used for choroidal angiography to determine the location of choroidal disorders. This drug was registered and declared as a Class 3 chemical drug, and is deemed to have passed the generic drug consistency evaluation.